Skip to main content
Close

UBC Children's and Women's Research Ethics Board

The University of British Columbia / Children’s and Women’s Health Centre of British Columbia Research Ethics Board (UBC C&W REB) is a UBC-affiliated Research Ethics Board (REB) for the Oak Street campus.

The UBC C&W REB is responsible for the ethical review of the following:

  • Clinical and Behavioural research projects conducted at:
    • BC Children's Hospital and Sunny Hill Health Centre for Children*
    • BC Mental Health & Addiction Services*
    • BC Women's Hospital & Health Centre*
    • BC Children's Hospital Research Institute
    • BC Mental Health & Addictions Research Institute
    • Women's Health Research Institute
*Agencies of the Provincial Health Services Authority

  • Studies for which the Principal Investigator holds appointments with the Children’s & Women’s Health Centre of British Columbia, which directly involve patients, records or resources of the Oak Street campus. This also includes research projects which involve the use of human remains, cadavers, tissue, biological fluids, embryos and/or fetuses.

Site-specific Requirements

  • Researchers must obtain institutional approval from C&W prior to commencing any human subject research studies taking place at C&W which use patient or other client populations, access medical or other records, or impact C&W clinical or other service resources in any way.  See our Institutional Approvals page for more details.
  • Researchers who do not hold a Children's & Women's appointment must appoint an individual who holds a Children's & Women's appointment as site lead or co-investigator for the research.

To enable researchers to secure funding from the US Department of Health and Human Services (DHHS), the UBC C&W REB and the Children's & Women's Health Centre of British Columbia have obtained OHRP Federalwide Assurance (FWA) and Institutional Review Board (IRB) Assurance.

Assurance

Number

Expiry Date

Federalwide Assurance (FWA)

FWA00020398

June 14, 2018

Children's and Women's Hospital IRB#1

IRB00006995

September 17, 2016

Every institution engaged in human subjects research supported or conducted by the US DHHS is required, under the DHHS human subjects protection regulations (45 CFR 46.103), to have an assurance of compliance approved by the US Office for Human Research Protections (OHRP).

The C&W assurance of compliance can be found here

‎The UBC C&W REB meets on the 4th Wednesday of each month, with the exception of the December meeting, which will take place on the 2nd Wednesday of the month.


The deadlines for full board review are listed below. Please note that there is no deadline for Minimal Risk studies.

Submissions must be received by 4:30 p.m. on the due date. Researchers are required to have their completed ethics application - including departmental approval - submitted to the UBC C&W REB prior to the submission deadline. Any submissions received after this time will be reviewed at the following month's meeting.

It is the Principal Investigator's responsibility to ensure that their department head has been notified of the application and ensure that departmental approval has been received prior to the deadline for submission. Departmental approval occurs electronically following Principal Investigator sign off on the application.

2017 Deadlines2017 Meetings
January 11January 25
February 8February 22
March 8March 29
April 12April 26
May 10May 24
June 14June 28
July 12July 26
August 9August 23
September 13September 27
October 11October 25
November 8November 22
November 29December 13

‎A fee for ethical review only applies only to research studies sponsored by industry (i.e., pharmaceutical, biological or medical device company) or any other for profit organization.


An initial application fee of $3,000 CAD per application covers the cost of the submission and initial review of the application. In addition, an annual renewal fee of $500 CAD will be levied (at the time of the annual renewal) to cover the cost of the annual renewal and other on-going oversight, including amendments and unanticipated events. The Principal Investigator must ensure the sponsor is aware of these fees. 

The UBC C&W REB Office will issue an invoice once your research project has been submitted on RISe. The Certificate of Approval will not be released until the review fee has been received. If you have outstanding fees, no new REB reviews will be undertaken until your account is brought into good standing.

If your study requires a Clinical Trial Agreement or Contract, a fully executed copy of the Clinical Trial Agreement or Contract must be on file with UBC’s University-Industry Liaison Office (UILO).  They will notify the REB when the agreement has been executed and ethical approval can then be released.

For a current statement of your fee account or other specific queries relating to REB fee payment, please contact:

Talysa Dhahan 
Administrative Coordinator, UBC C&W Research Ethics Board
tdhahan@bcchr.ubc.ca  | 604-875-3103 


Mechanism for submitting the fee

Internal Transfer from a C&W or PHSA account

Please return a copy of the invoice with the C&W or PHSA cost centre information as indicated and signatures from the appropriate authorizing signatory to the REB office.

Cheque

Payable to:Provincial Health Services Authority
Amount:$3, 000.00 CAD (for initial review) or $500.00 CAD (for annual renewal)
Reference:REB number (HXX-XXXXX)
Mail to:UBC C&W Research Ethics Board
Attention: Talysa Dhahan
Room A2-141A
950 West 28th Avenue
Vancouver, BC V5Z 4H4
Canada

Attach a copy of the invoice and include the REB number (HXX-XXXXX) as a reference.

Jennie Prasad, REB Manager

Jennie oversees the functioning of the REB staff and Board, monitors ethical review process standards, and advises on compliance with ethics policies. 

Ph: 604-875-2441; Email: jprasad@bcchr.ubc.ca

Farin Meralli, Pre-Post Review
Farin is responsible for the review of new full-board and minimal risk applications and associated deferral/proviso responses and general inquiries. 

Ph: 604-875-2000 ext.5396; Email: fmeralli@bcchr.ubc.ca

Talysa Dhahan, Administrative Coordinator  
Talysa is responsible for handling incoming general inquiries, post-approval activities, institutional approvals, and fee payment.

Ph: 604-875-3103; Email: tdhahan@bcchr.ubc.ca
 

Mailing Address & General Contact Information
UBC Children's & Women’s Research Ethics Board
Room A2-141A
950 West 28th Avenue
Vancouver, BC V5Z 4H4
CANADA

Phone: 604-875-3103
Fax: 604-875-2496 
 

SOURCE: UBC Children's and Women's Research Ethics Board ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © Provincial Health Services Authority. All Rights Reserved.

    Copyright © 2017 Provincial Health Services Authority